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Abstract
Hematopoietic stem cells (HSCs) are located in the bone marrow in a specific microenvironment referred as the
hematopoietic stem cell niche, where HSCs interact with a variety of stromal cells. Though several components of the stem
cell niche have been identified, the regulatory mechanisms through which such components regulate the stem cell fate are
still unknown. In order to address this issue, we investigated how osteoblasts (OBs) can affect the molecular and functional
phenotype of Hematopoietic Stem/Progenitor Cells (HSPCs) and vice versa. For this purpose, human CD34+ cells were
cultured in direct contact with primary human OBs. Our data showed that CD34+ cells cultured with OBs give rise to higher
total cell numbers, produce more CFUs and maintain a higher percentage of CD34+CD38- cells compared to control culture.
Moreover, clonogenic assay and long-term culture results showed that co-culture with OBs induces a strong increase in
mono/macrophage precursors coupled to a decrease in the erythroid ones. Finally, gene expression profiling (GEP) allowed
us to study which signalling pathways were activated in the hematopoietic cell fraction and in the stromal cell compartment
after coculture. Such analysis allowed us to identify several cytokine-receptor networks, such as WNT pathway, and
transcription factors, as TWIST1 and FOXC1, that could be activated by co-culture with OBs and could be responsible for the
biological effects reported above. Altogether our results indicate that OBs are able to affect HPSCs on 2 different levels: on
one side, they increase the immature progenitor pool in vitro, on the other side, they favor the expansion of the mono/
macrophage precursors at the expense of the erythroid lineage.
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Introduction
All hematopoietic cells are derived from Hematopoietic Stem
Cells (HSCs) which are endowed of two key functions: the self-
renewal capacity for the maintenance of a stable HSC pool in the
bone marrow (BM) and the differentiation capacity to give rise to
mature myeloid and lymphoid cells [1].
HSCs are located in the BM in a specific microenvironment
referred as the hematopoietic stem cell niche, which plays a pivotal
role in regulating their survival, self-renewal and differentiation.
HSCs are retained in a quiescent state in the BM, where they are
anchored to specialized niches along the endosteum and in
perivascular sites adjacent to the endothelium. In these specific
microenvironments, HSCs interact with a variety of stromal cells
including fibroblasts, endothelial cells, reticular cells, mesenchymal
stem cells, osteoblasts and adipocytes.
Osteoblasts (OBs) are key partecipants providing signals for
HSC trafficking, proliferation and survival. In 1994 Taichman RS
et al. firstly demonstrated that primary human OBs were able to
stimulate the proliferation of primitive CD34+ hematopoietic
progenitors in vitro [2]. Subsequently, it has been reported that
administration of parathyroid hormone (PTH) increases the
number of osteoblastic cells in the mouse system, leading to the
expansion of HSCs through Notch activation [3].
Communication between HSCs and OBs is essential for HSC
self-renewal and proliferation. Human OBs secrete cytokines, such
as granulocyte colony-stimulating factor, granulocyte-macrophage
colony-stimulating factor, and leukemia inhibitory factor, thus
supporting hematopoietic progenitor cell (HPC) function in vitro
[2,4,5].
Furthermore, OBs secrete angiopoietin-1 (Ang-1), thrombopoi-
etin (THPO), and stromal cell-derived factor 1 (SDF-1), which
regulate HSC maintenance. In particular, the interaction of Tie2
with its ligand Ang-1 maintains in vivo long-term repopulating
activity of HSCs, induces HSC adhesion to bone and forces HSCs
to become quiescent, suggesting that the Tie2/Ang-1 signaling
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pathway plays a critical role in the maintenance of mouse HSCs in
a quiescent state in the BM [6]. Recently, Yoshihara H. et al.
reported that mouse HSCs are in close contact to THPO-
producing osteoblastic cells at the endosteal surface in the
trabecular bone, suggesting the THPO/MPL pathway as a critical
component of the HSC osteoblastic niche [7]. Although several
components of the BM niche have been identified, how different
cellular elements collaborate to promote HSC self-renewal and to
maintain the stem cell pool is still unknown. In addition, the
regulatory mechanisms that contribute to the formation of a
quiescent or permissive microenvironment for HSC differentiation
still need to be identified. More importantly, most of our
knowledge on the hematopoietic stem cell niche comes from
transgenic mouse models, so it is not clear whether or not these
information can be transferred to the human system.
In the present study, we investigated how human primary OBs
can affect the molecular and functional phenotype of HSPCs and
vice versa in adherent co-culture system. Our data demonstrate
that OBs are able to expand the hematopoietic progenitor pool in
vitro and to induce a strong increase in the clonogenic activity of
human HSPCs. Moreover, our results pointed out that OBs are
also able to affect the differentiation capacity of CD34+ cells
favouring the expansion of the mono/macrophage lineage at the
expense of the erythroid and granulocytic ones. Finally, GEP
analysis enabled us to identify several cytokine-receptor networks
and transcription factors that could be activated by co-culture with




Human CD34+ cells were purified upon donor’s informed
written consent from umbilical Cord Blood (CB) samples, collected
after normal deliveries, according to the institutional guidelines for
discarded material (Clearance of Ethical Commitee for Human
experimentation of Modena: Segretary office Saverio Santachiara,
santachiara.saverio@policlinico.mo.it, approval date: 18.01.2005;
approval file number # 793/CE).
Human osteoblasts (OBs) were directly isolated from the
trabecular bone harvested from the inner portion of the tibia
plateau. The study was approved by the local Ethical Committee
and informed written consent was obtained from each patient
(Ethical Committee of Istituto Ortopedico Rizzoli, Secretary office
massimiliano.luppi@ior.it, Approved December 21, 2004,
Prot.141/CE/US/ML)
CD34+ stem/progenitor cell purification
Human CD34+ cells were purified from umbilical cord blood
(UCB) samples, as previously described [8]. CD34+ cell purity
assessed by flow cytometry was always .95%.
After purification, CD34+ cells were seeded in 24-well plates at
56105 cells/mL in Iscove’s modified Dulbecco’s medium (IMDM)
(GIBCO, Grand Island, NY, USA) containing 20% Human
Serum (Bio-Whittaker, Walkersville, MD, USA), SCF (50 ng/ml),
FLT3LG (50 ng/ml), TPO (20 ng/ml), IL-6 (10 ng/ml) and IL-3
(10 ng/ml) (all from R&D Systems, Minneapolis, MN, USA).
Isolation of human osteoblasts
Human OBs were directly isolated from the trabecular bone
harvested from the inner portion of the tibia plateau of 16 patients
undergoing total knee replacement for osteoarthritis (mean 6 SD
age 7068.2 years) as previously reported [9]. The bone chips were
fed with medium twice a week. After 2 weeks, they were removed
and the OBs were allowed to grow until confluent and analyzed at
the first and second passages.
Osteoblast proliferation and immunocytochemical
analysis
OBs were seeded in 96-well plates (56103 cell/well) and
incubated in 4 different media: CTR: consisting of DMEM/F12
medium supplemented with 20% FBS, COND.1: consisting of a
1:1 mixture of IMDM and DMEM/F12 supplemented with 20%
FBS, SCF 25 ng/ml, FLT3LG 25 ng/ml, TPO 10 ng/ml, IL-6
5 ng/ml and IL-3 5 ng/ml, COND.2: consisting of a 1:1 mixture
of RPMI and DMEM/F12 supplemented with 20% FBS, SCF
25 ng/ml, FLT3LG 25 ng/ml, TPO 10 ng/ml, IL-6 5 ng/ml and
IL-3 5 ng/ml, COND.3: consisting of a 1:1 mixture of IMDM and
DMEM/F12 supplemented with 20% FBS, SCF 5 ng/ml,
FLT3LG 5 ng/ml, TPO 2 ng/ml, IL-6 1 ng/ml and IL-3 1 ng/
ml. After 72 h, 3H-Thymidine (Amersham Pharmacia Biotech
Italia, Milan, Italy) was added at a final concentration of 2 mCi/ml
for 18 h at 37uC. At the end of the incubation time, the 96-well
plates were aspirated onto fiberglass filters using a Filtermate 196
Harvester (Packard Instrument Company, Meriden, CT, USA).
The filters were then dried and bound radioactivity was assayed by
liquid scintillation counting using a Top Count Microplate
Scintillation Counter (Packard Instrument Company). Data were
expressed as counts per minute6 S.D.
For immunocytochemical analysis OBs (16104/well) were
seeded in 8-well chamber slides and after 72 h fixed in 4% PFA
for 20 minutes at room temperature (RT) and then hydrated with
TBS 1% BSA for 5 minutes at RT. Cells were then incubated with
the following anti-human monoclonal antibodies: anti-RUNX-2,
anti-osteocalcin (R&D system, Minneapolis, MN, USA), and anti-
alkaline phosphatase (AP) (DSHB Department of Biological
Sciences, iowa City, IA, USA), for 1 hour at RT. The slides were
washed three times with TBS 1% BSA and then sequentially
incubated with multilinker biotinylated secondary antibody and
alkaline phosphatase-conjugated streptavidin (Biocaremedical,
Concord, CA, USA) at RT for 20 minutes. The slides were
developed using fast red as a substrate, counterstained with
haematoxylin, mounted with glycerol jelly and evaluated in a
brightfield microscope. Negative and isotype matched controls
were performed.
Co-culture condition
24 h after isolation, CD34+ cells were seeded directly onto
semiconfluent OB monolayers at a final density of 76103 cell/cm2
in 6-well plates. Cultures were maintained for 2 weeks in medium
consisting of a 1:1 mix of IMDM and DMEM/F12 (Dulbecco’s
Modified Eagle Medium: Nutrient Mixture F-12, both Celbio,
Italy) supplemented with 20% FBS (Lonza, Italy), SCF 5 ng/mL,
FLT3LG 5 ng/mL, TPO 2 ng/mL, IL-3 1 ng/mL and IL-6
1 ng/mL (all R&D Systems, Minneapolis, MN, USA), streptomi-
cin 100 mg/mL, penicillin 100 mg/mL and L-glutamine 2 mM (all
purchased from Celbio, Italy). In order to better assess erythroid
and megakaryocytic differentiation, cells were cultured in serum
free medium consisting of a 1:1 mix of of IMDM and DMEM/
F12 supplemented with 20% BIT (StemCell Technologies,
Vancouver, Canada), SCF 5 ng/mL, FLT3LG 5 ng/mL, TPO
1 ng/mL, IL-6 1 ng/mL (all R&D Systems, Minneapolis, MN,
USA), streptomicin 100 mg/mL, penicillin 100 mg/mL and L-
glutamine 2 mM (all Celbio, Italy). Cells were harvested by
trypsinization and vigorous pipetting on days 3, 7, 10 and 14 of co-
culture.
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Isolation of CD34+ cells and osteoblasts from co-cultured
samples
The separation of CD34+ cells from OBs was performed using a
magnetic cell sorting procedure (EasySep Human CD34+ positive
selection kit, StemCell Techonologies Inc.; Vancouver, Canada).
The fraction of CD34+ cells that was not cultivated on OB layers
(CD34+ CTR) was sorted using the same parameters to exclude
differences in clonogenic activity and gene expression due to a
different treatment. CD34+ cell purity assessed by flow cytometry
was .95% for both co-cultured and control samples. On the other
hand, OBs were purified from the hematopoietic cells based on the
expression of the pan-leukocyte marker CD45. CD45-negative
cells were isolated by means of negative-selection magnetic beads
sorting from the cells collected after co-culture. Purity of OBs
preparations was assessed firstly by flow cytometric analysis of
CD45 expression and subsequently by immunocytochemical
staining of OB-specific markers, such as RUNX-2, Osteocalcin,
Alkaline Phosphatase and Collagen type I as described above. The
percentage of positive cells was measured on 10 RGD images
acquired for each marker by image analysis with Software NIS
Element (Eclipse 90 I, Nikon) using an objective at 106
magnification.
Immunophenotypic analysis
Differentiation of CD34+ cells was monitored by flow cytomet-
ric analysis (BD FACSCanto II, Becton Dickinson, USA) of CD14,
CD34, CD38, CD41, CD66b, CD163, MPO, and GPA
expression, performed at days 3, 7,10 and 14 of culture, as
previously described [10]. The values relative to immunopheno-
typic analysis are reported as 6 2S.E.M from ten independent
experiments.
Immunofluorescent staining
Cytospins of CD34+ cells were fixed with 4% paraformaldehyde
(PFA) and permeabilized using 0.3% Triton X-100 in PBS for
10 minutes. After blocking with 3% BSA in PBS, slides were
incubated with rabbit monoclonal anti-human collagen type I
(COL1A1) antibody (Invitrogen, Carlsbad, CA) at 1:500 dilution
and with mouse monoclonal anti-human CD34 antibody (Becton
Dickinson, BD) at 1:50 dilution for 1 h at 37uC. This was followed
by incubation with goat anti-rabbit Alexa Fluor 568-conjugated
and goat anti-mouse Alexa Fluor 488-conjugated secondary
antibodies (Invitrogen, Carlsbad, CA) at 1:2000 dilution for 1 h
at 37uC. All incubations were followed by 3 washes with PBS
solution. Nuclear counterstaining was performed with 49,6-
diamino-2-phenylindole (DAPI). The slides were mounted with
Vectashield Mounting Medium (Vector Laboratory Inc). Finally,
fluorescence imaging was performed using the Zeiss LSM 510
Meta Confocal Microscope (Zeiss, Germany) and digital images of
representative areas were taken. To ensure random sampling, 50
images/slide were captured and cells positive for Col1a1 were
scored.
Methylcellulose clonogenic assay
Human Colony Forming Cells (CFUs) were cultured in
methylcellulose as previously described [11]. After 14 days of
culture at 37uC in a humidified atmosphere with 5% CO2,
erythroid burst-forming units (BFU-E), erythroid colony-forming
units (CFU-E), colony-forming units granulocyte (CFU-G), mac-
rophage (CFU-M), granulocyte-macrophage (CFU-GM), and
colony-forming units granulocyte/erythrocyte/macrophage/
megakaryocyte (CFU-GEMM) were scored. The values are
reported as 6 2S.E.M from five independent experiments.
RNA extraction and microarray analysis
Total cellular RNA was extracted after 3 days of treatment from
0.36106 cells of each sample using RNeasy Micro kit (Qiagen,
Valencia, CA) following the protocol supplied by the manufac-
turer. For both CD34+ cells and OBs, total RNA pools (100 ng) of
Control (CTR) and co-culture (COCULT) cells, obtained from 5
independent experiments, were converted in biotinilated aRNA
according to the GeneChip 39 IVT Express Kit protocol advised
by Affymetrix. Similarly, the Affymetrix Human HG-U133plus2
GeneChip arrays hybridization, staining, and scanning, were
performed using Affymetrix standard protocols (Affymetrix, Santa
Clara,CA) as previously described [10].
The GeneChip Operating Software (GCOS) absolute analysis
algorithm was used to determine the amount of a transcript
mRNA (Signal), while the GCOS comparison analysis algorithm
was used in order to compare gene expression levels between two
samples.
Differentially expressed genes were selected as the sequences
showing a Change call ‘‘I’’ or ‘‘D’’ and Signal Log Ratio $1 or
#21 in the pair-wise comparisons between COCULT and CTR
cells.
All the data have been deposited in the Gene Expression
Omnibus MIAME compliant public database, at http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE38091.
DAVID 6.7 (National Institute of Allergy and Infectious
Diseases, http://david.abcc.ncifcrf.gov/) was used to examine
selected lists of genes in order to identify over-representation of
functional categories according with gene-ontology classification.
To validate microarray data, a set of modulated genes was
monitored by quantitative real-time (QRT) PCR as previously
described [8], for assay IDs see Table 1.
Statistical analysis
The statistics used for data analysis (CD34+ COCULT vs
CD34+ CTR) was based on the two-tail t-Student test for averages
comparison in paired samples. Data were analyzed by Microsoft
Excel Software (version 2007) and p,0.05 was considered
significant.
Table 1. Assay IDs for quantitative real-time (QRT) PCR.
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Results
OBs support Hematopoietic Stem Progenitor Cell (HPSC)
expansion and function
CD34+ cells from UCB were cultured for 14 days in either
liquid culture or over a monolayer of human primary OBs isolated
from the trabecular bone. Co-cultures of OBs and HPCs were
initiated (day 0) 24 hours after CD34+ cells isolation from UCB by
seeding 76103 CD34+ cells/cm2 on a subconfluent monolayer of
OBs. Cultures were supplemented with exogenous cytokines as
detailed in Material and Methods.
In preliminary experiments, multiple mixes of media and
decreasing doses of hematopoietic cytokines were tested in order to
determine the mix of media capable of supporting both osteoblasts
and CD34+ cells without modifying cell growth and differentiation
properties (Figure S1, S2 and S3).
First of all, we investigated the ability of human primary OBs to
support hematopoietic stem/progenitor cells in culture. After 3
and 7 days, fold increase in total cell number generated from
CD34+ cells, isolated as described in Material and Methods from
co-culture and Control samples, was significantly (p#0.05) higher
in co-culture compared with control liquid culture (28,663,1 vs
18,5761,8-fold at day 3, 102,868,9 vs 58,6167,6-fold at day 7)
(Figure 1A). CD34+ cells were also assessed for their colony-
forming ability in methylcellulose-based assay. The number of
CFUs generated by CD34+ cells increased by 260,4 fold when
CD34+ cells were cultured with OBs as compared to being
cultured alone (Figure 1B). The progeny of CD34+ cells was also
assessed for CD34 and CD38 antigen expression at day 3 and 7 of
culture. The percentage of CD34+CD38- cells was significantly
(p#0.05) higher in the co-culture compared to the control sample
(0,660,1% vs 0,260,05% at day 3, 1,260,3% vs 0,160,05% at
day 7) (Figure 1C and 1D), suggesting that the maintenance of
CD34+CD38- cells may be responsible for the increase in CFU
output of co-cultured HPCs. This increase in the percentage of
CD34+CD38- cells translates into a 5-fold increase and a 23-fold
increase at day 3 and 7 respectively, if we take into account the
raise in total cell number generated by CD34+ cells co-cultured
with OBs (absolute numbers of CD34+CD38- cells at day 3 and
day 7 of co-culture are shown in table in Figure 1).
Taken together, the increase in total cell number, the higher
number of clonogenic cells and the increased percentage of
CD34+CD38- cells suggest that OBs are able to enhance HSPC
properties, by promoting their expansion while maintaining a
primitive phenotype.
Impact of OBs on HPSC differentiation capacity
To better characterize the effects of OBs on stem/progenitor
cell differentiation, CD34+ cells purified from control and co-
culture samples at day 3 were plated in methylcellulose-based
Figure 1. Co-culture with OBs supports hematopoietic stem and progenitor cell function. 76103 CD34+ cells were cultured alone or in
presence of freshly prepared OBs for 3 and 7 days and the following parameters were measured: (A) Fold increase in total cell number calculated from
the original CD34+ cells seeded at day 0. (B) Total CFU output for Control and Co-culture CD34+ cells, cells were plated at day 3 of culture and
colonies were scored 14 days after plating; (C) percentage of CD34+CD38- cells; and (D) percentage of CD34+CD38- cell population present in Control
and Co-cultured samples at day 7, representative flow cytometry is shown. Absolute numbers of CD34+CD38- cells at day 3 and day 7 of co-culture
are shown in table. Values are reported as mean 6 2SEM., * = p,0.05 versus Control. Abbreviation: CTR, control.
doi:10.1371/journal.pone.0053496.g001
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medium in a set of five independent experiments. As described
above, clonogenic assay results demonstrated that the clonogenic
capacity of CD34+ cells co-cultured with OBs was increased by 2
fold (Figure 1B–C). Interestingly, the methylcellulose-based
clonogenic assay showed a significant increase (p#0.001) of the
percentage of monocyte (CFU-M) colonies in OB-co-cultured
CD34+ cells coupled to a decrease of the erythroid ones (BFU-E),
while granulocytic progenitors (CFU-G) were not significantly
affected (Figure 2A).
The effects of OBs on CD34+ cells were also evaluated in long-
term co-culture. CD34+ cells were seeded at 76103 cell/cm2 on a
monolayer of primary human OBs. At day 10 and 14 of co-
culture, the cells were harvested by trypsinization and vigorous
pipetting in order to dissociate hematopoietic cells strictly adherent
to OBs and analyzed for the expression of lineage differentiation
markers. Flow cytometric analysis was performed at day 10 on
GPA and CD41, respectively erythroid and megakaryocytic
markers, and at day 14 on the mono/macrophage markers
CD14 and CD163, and on the granulocytic markers MPO and
CD66b (Figure 2B). Our data showed an increase in the
percentage of cells positive for the mono/macrophage markers
coupled to a decrease in the percentage of cells positive for the
granulocytic and erythroid markers, whereas the megakaryocytic
marker CD41 was not modulated (data not shown). Overall, these
results indicate that co-culture with OBs induces a strong
expansion of the mono/macrophage lineage coupled to a decrease
in the percentage of erythroid-committed cells.
Gene Expression Profile (GEP) of CD34+ cells co-cultured
with OBs
Next, we investigated the changes in gene expression induced in
HPCs by co-culture with primary human OBs, using Affymetrix
HGU133Plus2 GeneChip array. Microarray analysis was per-
formed on CD34+ cells isolated at day 3 of co-culture based on the
observation that such timing was sufficient to exert a significant
modulation of HSPC clonogenic and differentiation capacity in
methylcellulose-based assay.
Using the filtering procedure described in Material and
Methods, we identified a list of genes significantly modulated in
CD34+ cells by OB coculture (486 probesets increased, 110
probesets decreased in CD34+COCULT versus CD34+Control).
DAVID 6.7 analysis showed that the ‘‘Positive regulation of cell
proliferation’’, ‘‘Cell differentiation’’, ‘‘Regulation of Wnt receptor
signaling pathway’’ GO categories are mainly represented in the
gene list of probesets increased in CD34+COCULT vs
CD34+Control cells (Table S1A). Consistently with the adhesion
of the HSPCs to the osteoblastic layer observed in co-culture, the
GO categories ‘‘Cell Adhesion’’ and ‘‘Extracellular matrix
organization’’ are significantly represented in the list of increased
genes. Conversely, GO categories down-regulated by coculture
with OBs include ‘‘Oxygen transport’’ and ‘‘Erythrocyte differen-
tiation’’ (Table S1B), in agreement with the down-regulation of
the erythroid development reported above.
As shown in Figure 3A, detailed analysis of microarray data
showed the up-regulation of several genes involved in the OB-
mediated maintenance of hematopoietic stem/progenitor cells
such as components of the WNT pathway [12] (WNT5a, FZD7,
DACT1, DKK1, DKK3, and SFRP4) [13]. GEP analysis revealed
also the up-regulation of genes taking part in HSC adhesion to the
BM niche, such as N-cadherin (N-CAD) [14,15] and LAYN, a
newly identified hyaluronan receptor [16]. Moreover, co-culture
with OBs induces the up-regulation of Jagged1 (JAG1) [17], GAS6
and its receptor Axl [18], which are involved in the maintenance
of HSCs in a quiescent state. Among up-regulated genes were also
found several chemokines and pro-inflammatory cytokines, such as
CCL4, IL1A, IL1B and CCL20, that, as already reported by
Majka M. et al. [19], can be secreted by hematopoietic precursors
and regulate with an autocrine and/or paracrin mechanism the
various stages of hematopoiesis. Moreover, GEP analysis showed a
strong increase in the expression level of several extracellular
matrix components such as, collagen type I (COL1A1), fibronectin
1 (FN1) and laminin-b1 (LAMB1) in CD34+ co-cultured cells.
Finally, some transcription factors that could play a role in the
regulation of HSCs survival and maintenance, such as Egr1 [20],
Foxc1 [21] and Twist1 [22], were similarly increased in CD34+
co-cultured cells vs control.
On the other hand, among down-regulated genes, we found
several genes coding for proteins involved in erythroid differen-
tiation, such as Glycophorin B (GYPB) [23], globin genes (HBA1)
and Rh-associated glycoprotein (RHAG) [24] (Figure 3A).
In order to confirm microarray data, we carried out a TaqMan
QRTPCR analysis on a validation set selected among the
differentially expressed genes between CD34+COCULT versus
CTR sample. All the assessed genes showed in QRT-PCR the
same expression pattern obtained by microarray analysis
(Figure 3B).
Figure 2. Differentiation capacity of CTR and co-cultured
CD34+ cells. (A) Results of statistical analysis of methylcellulose-based
clonogenic assay performed on CD34+ cells plated after 3 days of co-
culture with human OBs and scored after 14 days. (A) Count of different
colony types; (B) Results of statistical analysis on the percentage of cells
positive for hematopoietic lineage differentiation markers (GPA, CD66b,
MPO, CD14, and CD163) performed by flow cytometry at day 10 and 14
of co-culture. Values are reported as mean 6 2S.E.M., * = p#0.05 vs CTR,
** = p#0.001 vs CTR. The results come from five independent
experiments. Abbreviations: BFU-E, Burst forming unit-erythroid; CFU,
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In order to rule out the possibility of OBs contamination in the
CD34+ cell fraction that could affect GEP results, immunofluo-
rescence (IF) analysis for collagen type I was performed on CD34+
cells purified after co-culture (Figure S4). Collagen type I was
chosen as it represents a specific marker for OBs [25] and, at the
same time, it’s strongly up-regulated in CD34+ cells after co-
culture. IF confirmed the up-regulation of collagen type I in
CD34+ co-cultured cells compared to control (Figure 4) strongly
suggesting that collagen type I and CD34 antigen are expressed on
the same cell (Figure 5) and excluding the possibility that the up-
regulation observed by GEP analysis was due to OBs contamina-
tion of the CD34+ cell preparation.
Gene Expression Profile (GEP) of OBs co-cultured with
CD34+ cells
In order to investigate the changes induced in OBs by co-culture
with human HSPCs, we performed GEP analysis on control and
co-cultured OBs by means of Affymetrix HGU133Plus2 Gene-
Chip array. OBs were isolated at day 3 of co-culture as described
in Material and Methods. Purity of OBs cell preparation was
examined both by flow cytometric analysis and immunocyto-
chemical staining for OBs-specific markers. Results, shown in
Figure S5 A–D, demonstrate that OBs, purified by magnetic
bead sorting based on the lack of expression of the CD45 antigen,
are in fact 92% negative for CD45 while being positive for several
Figure 3. Changes in gene expression profile induced by co-culture in OBs and CD34+ cells. (A) Microarrays analysis was performed at
day 3 of co-culture on pooled RNAs from Control and co-cultured CD34+ cells from five independent experiments. Changes in gene expression are
reported on the x-axis as signal log ratio (SLR). (B) Expression levels of 13 genes selected as differentially expressed from microarrays data. Gene
expression levels were measured by Real-Time Quantitative Polymerase Chain Reaction PCR (RTQPCR) starting from total RNA and were expressed as
log10 of Relative Quantity. Results come from five independent experiments. (C) Results of microarrays analysis performed at day 3 of co-culture on
pooled RNAs from Control and co-cultured OBs from five independent experiments. Changes in gene expression are reported on the x-axis as signal
log ratio (SLR).
doi:10.1371/journal.pone.0053496.g003
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OB-specific markers, such as RUNX-2, Osteocalcin, Alkaline
Phosphatase (AP) and Collagen type I (COL1A1) (Figure S5E).
Using the filtering procedure described in Material and
Methods, we identified a list of genes significantly modulated in
OBs after co-culture with CD34+ cells (198 probesets increased,
125 probesets decreased in OB COCULT versus OB Control).
Detailed analysis of differentially expressed genes pointed out
the increased expression in OBs co-cultured cells of transcripts
coding for cytokines and chemokines involved in the maintenance
of HSCs in a quiescent state, such as CCL2 [26], CCL3 [27] and
CXCL2 [28] (Figure 3C). Interestingly, co-cultured OBs also
showed the up-regulation of CXCL12, which is responsible for
HSC migration and retention in the BM niche [29] and of
Osteopontin (OPN), which is a hematopoietic stem cell niche
component that negatively regulates stem cell pool size [30].
Finally, worth of notice is the up-regulation of several adhesion
molecules, such as ICAM1 [31] and PECAM1 [32], that could
mediate HSPC adhesion to osteoblast cells.
Discussion
Self-renewal and differentiation divisions of HSCs are tightly
regulated by the stem cell niche in the bone marrow. The balance
between differentiation and maintenance of the stem cell pool is
regulated by complex molecular mechanisms involving a large
number of soluble factors and cell-cell interactions. BM stromal
cells are key participants of the regulatory machinery governing
hematopoietic development. HSCs and osteoblasts are both
located near the endosteal surface suggesting a functional
relationship between these two cellular populations. Several
authors reported that depletion of OBs causes mobilization of
hematopoietic stem and progenitor cells to the spleen [33] and, on
the other hand, an increase in OB numbers induces a
simultaneous increase in HSCs in the BM [34]. In this paper,
we sought to examine which regulatory mechanisms are able to
regulate the balance between self-renewal and differentiation in
the endosteal niche. In order to address this issue we set up a co-
culture system composed of human CD34+ cells purified from the
CB and human trabecular OBs. Our results demonstrate that co-
culture with OBs induces a 23-fold expansion of the hematopoietic
progenitor pool and a strong increase in the clonogenic capacity of
CB CD34+ cells. Moreover, our data pointed out for the first time
the ability of osteoblast cells to affect HSPC differentiation by
favoring the expansion of the mono/macrophage lineage at the
expense of the erythroid one.
In the presence of OBs, CD34+ cells gave rise to higher total cell
numbers, produced more CFUs and maintain a higher percentage
of CD34+CD38- cells compared to control culture.
The percentage of CD34+CD38- cells was significantly
(p#0.05) higher in the co-culture compared to the control sample
(Figure 1C), translating into a 5-fold increase and a 23-fold
increase, at day 3 and 7 respectively, if we take into account the
raise in total cell number generated by CD34+ cells co-cultured
with OBs. At the same time, co-culture with OBs induces a strong
increase in the clonogenic capacity of CD34+ cells (Figure 1B),
suggesting that the maintenance of CD34+CD38- cells may be
responsible for the increase in CFU output of co-cultured HPSCs.
Taken together, our results suggest that OBs are able to
enhance HPC properties, by promoting their expansion while
maintaining a primitive phenotype.
Several authors already reported the ability of OBs to support
hematopoietic stem/progenitor cell functions, such as self-renewal
and long-term repopulating capacity [35,36], but to our knowl-
edge, no data is available regarding the capacity of OBs to affect
HPC differentiation capacity.
In order to dissect this issue, CD34+ cells purified after 3 days of
co-culture with OBs were plated in methylcellulose-based medium
and colony numbers and types were scored at day 14. Clonogenic
assay results showed a significant increase (p#0.001) of the
percentage of macrophage (CFU-M) colonies in OB-co-cultured
CD34+ cells coupled to a decrease of the erythroid ones (BFU-E)
(Figure 2A). The effects of OBs on HPSCs were also evaluated in
long-term co-culture. Flow cytometric analysis of lineage differen-
tiation markers showed an increase in the percentage of cells
Figure 4. Up-regulation of collagen type I in CD34+ co-cultured
cells. Immunofluorescence analysis of collagen type I on human CD34+
cells grown without (Control) or with human primary osteoblasts. Cells
were labelled with anti-collagen type I antibody (red fluorescence) and
nuclear counterstaining was performed with DAPI (blue fluorescence).
In the upper panels, absence of collagen type I expression in
CD34+Control cells is shown (A and C). In the lower panels, expression
of collagen type I in CD34+ Co-culture (D and F) is shown. Col1A1 is
absent on Control CD34+ cells, whereas it is present on the 9261,3% of
Co-culture CD34+ cells.
doi:10.1371/journal.pone.0053496.g004
Figure 5. Co-expression of collagen type I and CD34 antigen on
CD34+ co-cultured cells. Immunofluorescence analysis of collagen
type I on human CD34+ cells grown in co-culture with human primary
osteoblasts. Cells were labelled with anti-collagen type I antibody (red
fluorescence) and with anti-human CD34 antibody (green fluorescence);
nuclear counterstaining was performed with DAPI (blue fluorescence).
Co-expression of collagen type I and CD34 antigen was assessed,
evaluating the presence of green and red fluorescence in the same cell
(D).
doi:10.1371/journal.pone.0053496.g005
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positive for the mono/macrophage markers CD14 and CD163
coupled to a decrease in the percentage of cells positive for the
granulocytic (MPO, CD66b) and erythroid (GPA) markers
(Figure 2B). Overall, these results indicate that OBs support
the expansion of mono/macrophage committed cells while
inhibiting the erythroid precursors.
At the aim of characterizing the molecular mechanisms
responsible for the biological effects reported above, Gene
Expression Profiling (GEP) of CD34+ CTR and CD34+ co-
cultured cells was performed. It is important to notice that GEP
analysis was performed on highly purified cell populations, as
shown in Figures S4 and S5. Previous reports attempting to
study gene expression profile of hematopoietic cells after culture
on stromal layers were unable to separate the hematopoietic cell
fraction from the adherent osteoblast cells, consequently the results
obtained were strongly compromised by the contamination of the
stromal component in the total RNA preparation [36]. In this
paper, we were able to separate the CD34+ cells from the
remaining osteoblasts and hematopoietic cells, in order to study
the changes in gene expression profile induced in HPSCs by the
co-culture with human OBs. Our microarray data showed the up-
regulation in CD34+ co-cultured cells of several genes already
reported as key players in the maintenance of hematopoietic stem/
progenitor cell in the BM (Figure 3A), such as components of the
WNT pathway [12] (WNT5a, FZD7, DACT1, DKK1, DKK3,
and SFRP4) and the adhesion molecule N-Cad, that has been
shown to regulate HSCs adhesion to the bone lining osteoblasts
[37]. Microarray data highlighted not only previously reported
components of the osteoblastic stem cell niche, but also showed the
up-regulation of a number of genes, not previously described in the
context of the BM niche, that could be involved in the signaling
network between osteoblasts and HPSCs. For example, the
adhesion molecule LAYN, a newly identified hyaluronan receptor
[16], could mediate HSPC adhesion to the BM niche, or the
signaling network GAS6-Axl, up-regulated after co-culture, could
support hematopoietic activity by maintaining HSPCs in a
quiescent state [18]. Moreover, GEP analysis showed a strong
increase in the expression level of transcription factors that could
play a role in the regulation of HSPC survival and maintenance,
such as Egr1, Foxc1 and Twist1. Egr1 has been recently described
as transcriptional regulator that normally functions to promote
HSC quiescence and retention in the BM niche [20]. Foxc1 is a
member of the Forkhead/Fox transcription factor family, mainly
expressed in mesodermal and neural crest derivatives during
development [38], whose expression and function in the hema-
topoietic system has never been described. Recently, Bloushtain-
Qimron N. et al. reported that constitutive expression of Foxc1 in
differentiated mammary epithelial cells results in the conversion of
the differentiated epithelial phenotype into a progenitor-like
phenotype [21]. Thus, the up-regulation of Foxc1 in HSPCs after
co-culture with human OBs could be involved in the maintenance
of the primitive progenitor phenotype observed in vitro.
Twist1 is a highly conserved basic helix-loop-helix transcription
factor involved in several pathways that control tumor growth,
apoptosis, differentiation, and epithelial–mesenchymal transition
[39,40]. Twist1 directly interacts with and opposes p53 function
[41], up-regulation of Twist1 has been reported in several human
cancers [42,43,44] suggesting that Twist1 functions as an
oncogene. In our culture system, Twist1 up-regulation in
CD34+ co-cultured cells could favour HSPC survival and this
could account, at least in part, for the increase in total cell
numbers and CFU output described above.
Conversely, GEP analysis revealed the down-regulation of
several genes coding for protein involved in erythroid differenti-
ation, such as Glycophorin B (GYPB) [23], globin genes (HBA1)
and Rh-associated glycoprotein (RHAG) [24] (Figure 3A). This
down-modulation is in agreement with the reduction in erythroid
precursors observed both in liquid and semisolid culture.
On the other hand, GEP analysis performed on OBs purified
after co-culture revealed the up-regulation of several genes
involved in the regulation of the BM stem cell pool size, such as
CCL2 (26), CCL3 [27], CXCL2 [28] and OPN [30,45], and of
genes mediating HSC adhesion and retention in the BM stem
niche, such as CXCL12 [29], ICAM1 [31] and PECAM1 [32].
Altogether our results indicate that osteoblasts support and
influence both maintenance and later differentiation of HSPCs. In
the short-term culture, our data demonstrate that OBs are able to
enhance HSPC clonogenic capacity and to expand hematopoietic
progenitors pool. On the other hand, in the long-term, osteoblasts
are able to affect HSPC differentiation, by favoring the mono/
macrophage lineage and inhibiting the erythroid one. Moreover,
our microarray data allowed us to identify specific signaling
pathways and regulatory networks involved in HSPC-osteoblast
interaction that could account for the biological effects exerted by
OBs on CD34+ cells. In particular, GEP analysis pointed out the
up-regulation of several transcription factors, such as TWIST1
and FOXC1, that could play a critical role in HSPC self-renewal
and maintenance. Taken together, our data allows us to get new
insights on the molecular mechanisms underlying HSPC mainte-
nance and differentiation in the osteoblastic stem cell niche.
Supporting Information
Figure S1 Hematopoietic cell culture conditions testing.
Multiple mixes of media and decreasing doses of hematopoietic
cytokines were tested in order to determine the mix of media
capable of supporting CD34+ cells without modifying cell growth
and differentiation properties. 24 h after isolation, CD34+ cells
were seeded at a final density of 76103 cell/cm2 in 6-well plates.
Cultures were maintained for 2 weeks in 4 different culture
conditions: CTR: consisting of Iscove’s modified Dulbecco’s
medium (IMDM) supplemented with 20% FBS, SCF (50 ng/
ml), FLT3LG (50 ng/ml), TPO (20 ng/ml), IL-6 (10 ng/ml) and
IL-3 (10 ng/ml); COND.1: consisting of a 1:1 mixture of IMDM
and DMEM/F12 supplemented with 20% FBS, SCF (25 ng/ml),
FLT3LG (25 ng/ml), TPO (10 ng/ml), IL-6 (5 ng/ml) and IL-3
(5 ng/ml), COND.2: consisting of a 1:1 mixture of RPMI and
DMEM/F12 supplemented with 20% FBS, SCF (25 ng/ml),
FLT3LG (25 ng/ml), TPO (10 ng/ml), IL-6 (5 ng/ml) and IL-3
(5 ng/ml), COND.3: consisting of a 1:1 mixture of IMDM and
DMEM/F12 supplemented with 20% FBS, SCF (5 ng/ml),
FLT3LG (5 ng/ml), TPO (2 ng/ml), IL-6 (1 ng/ml) and IL-3
(1 ng/ml). Cell cycle analysis, performed at day 3 (A) and 7 (B) of
culture by propidium iodide staining, showed no difference
between the 3 culture conditions tested and the CTR sample.
Flow cytometric analysis of the percentage of CD34+CD38- cells
(C), performed at day 3 of culture, revealed no difference between
the CTR and the 3 conditions tested. In the same way, results (D)
of statistical analysis on the percentage of positive cells for lineage
differentiation markers (GPA, MPO and CD14) performed by
flow cytometry at day 10 of culture, showed no difference between
CTR and the 3 different culture conditions.
(TIF)
Figure S2 OBs culture conditions testing results. Multi-
ple mixes of media and decreasing doses of hematopoietic
cytokines were tested in order to determine the mix of media
capable of supporting OBs without modifying cell growth. OBs
were seeded in 96-well plates (56103 cell/well) and maintained for
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72 hours in 4 different culture conditions: CTR: consisting of
DMEM/F12 medium supplemented with 20% FBS, COND.1:
consisting of a 1:1 mixture of IMDM and DMEM/F12
supplemented with 20% FBS, SCF (25 ng/ml), FLT3LG
(25 ng/ml), TPO (10 ng/ml), IL-6 (5 ng/ml) and IL-3 (5 ng/
ml), COND.2: consisting of a 1:1 mixture of RPMI and DMEM/
F12 supplemented with 20% FBS, SCF (25 ng/ml), FLT3LG
(25 ng/ml), TPO (10 ng/ml), IL-6 (5 ng/ml) and IL-3 (5 ng/ml),
COND.3: consisting of a 1:1 mixture of IMDM and DMEM/F12
supplemented with 20% FBS, SCF (5 ng/ml), FLT3LG (5 ng/ml),
TPO (2 ng/ml), IL-6 (1 ng/ml) and IL-3 (1 ng/ml). Cell
proliferation analysis, performed by 3H-thymidine incorporation,
demonstrated that only COND.3 does not modify cell prolifera-
tion compared to the CTR sample. Data were expressed as counts
per minute6 S.D.
(TIF)
Figure S3 OBs culture conditions testing results. Multi-
ple mixes of media and decreasing doses of hematopoietic
cytokines were tested in order to determine the mix of media
capable of supporting OBs without modifying cell properties. OBs
(16104/well) were seeded in 8-well chamber slides and maintained
for 72 hours in 4 different culture conditions: CTR, COND.1,
COND.2, COND.3. Slides were then incubated with the following
anti-human monoclonal antibodies: anti-RUNX-2 (panel A), anti-
osteocalcin (panel B), and anti-alkaline phosphatase (AP) (panel C).
Data shown in panel B and C demonstrate that all the three
different culture conditions tested do not modify osteocalcin and
alkaline phosphatase expression compared to the CTR sample.
On the other hand, RUNX2 expression (panel A) appears to be
down-regulated in COND.1 and COND.2 compared to the CTR,
whereas it appears similar in COND.3 and in the CTR sample.
Our data demonstrate that COND.3 is the culture condition
capable of maintaining OBs similar to CTR culture condition,
therefore COND.3 has been applied in all the experiments
reported in this study.
(TIF)
Figure S4 CD34+ cell isolation from co-culture samples.
At day 3 of co-culture, CD34+ cells were separated from OBs by
magnetic beads sorting, after separation cells were stained with an
anti-human CD34 monoclonal antibody to assess cell purity. Data
shown are representative flow cytometry of CD34+ cells before (B)
and after (D) magnetic beads sorting.
(TIF)
Figure S5 OBs isolation from co-culture samples. At day
3 of co-culture, OBs were separated from the hematopoietic cells
by magnetic beads sorting, after separation cells were stained with
an anti-human CD45 monoclonal antibody to assess cell purity.
Data shown are representative flow cytometry of OBs before (A, B)
and after (C,D) magnetic beads sorting. Freshly isolated OBs (E)
and cytospin of CD45- cells (F) were fixed for immunocytochem-
ical analysis of Alkaline Phosphatase (AP), RUNX-2, Osteocalcin
and Collagen type I (Coll.I). The percentage of positive cells was
measured on 10 RGD images acquired for each marker by image
analyzer (NIS-Nikon) using an objective at 106magnification.
(TIF)
Table S1 A. GO categories Increased in CD34+COCULT
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